Agilent also is providing Mass Profiler Professional software program to help Stemina researchers interpret the complex data generated by metabolomics experiments. Related StoriesNew era of RNAscope items for RNA-biomarker analysis in FFPE cells releasedOJ Bio at Medica 2015 – Point of Care diagnostics' function in reducing antibiotics prescribingResearchers introduce free of charge iOS app to understand about autism in small children’We are pleased to broaden our relationship with Agilent to progress our scientific platform and our discovery of essential small molecules involved with developmental toxicity and autism,’ stated Beth Donley, Stemina CEO. ‘We have utilized Agilent technology since Stemina began operations in 2007 and also have been very pleased with the instrumentation, support and collaboration we have experienced with Agilent.’ ‘Metabolomics is a major growth area for all of us, and the innovative work being done at Stemina may be the kind we like to support,’ said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division.Significant gastrointestinal perforation occurred in one patient 38 days post-cholecystectomy. Embryo-Fetal Toxicity: Iclusig could cause fetal harm. If Iclusig can be used during being pregnant, or if the individual becomes pregnant while taking Iclusig, the patient ought to be apprised of the potential hazard to the fetus. Advise women in order to avoid pregnancy while taking Iclusig. Hematologic effects included thrombocytopenia, anemia, neutropenia, lymphopenia, and leukopenia.